Complex I is the first and largest enzyme in the respiratory chain and is located in the inner mitochondrial membrane. Complex I deficiency is the most commonly reported mitochondrial disorder presenting in childhood, but the molecular basis of most cases remains elusive. We describe a patient with complex I deficiency caused by mutation of the molecular chaperone FOXRED1. A combined homozygosity mapping and bioinformatics approach in a consanguineous Iranian-Jewish pedigree led to the identification of a homozygous mutation in FOXRED1 in a child who presented with infantile-onset encephalomyopathy. Silencing of FOXRED1 in human fibroblasts resulted in reduced complex I steady state levels and activity, whilst lentiviral mediated FOXRED1 transgene expression rescued complex I deficiency in the patient fibroblasts. This FAD-dependent oxidoreductase, which has never previously associated with human disease, is now shown to be a complex I-specific molecular chaperone.
INTRODUCTION
Complex I (NADH:ubiquinone oxidoreductase, EC 1.6.5.3) is the largest enzyme in the inner mitochondrial membrane and provides the entry point into the respiratory chain for electrons derived from fuel oxidation. However, despite its fundamental role in mitochondrial energy generation, complex I remains the least well understood of the respiratory chain complexes.
Although the crystal structure has been elucidated (1), little is known about the function of many of the 45 subunits, and the factors necessary for and mechanisms of assembly of this macromolecular complex remain largely unknown.
Mitochondrial diseases are characterised by extreme clinical, biochemical and genetic heterogeneity (2) . Isolated deficiency of complex I is the most commonly identified biochemical defect in childhood-onset mitochondrial disease (3) . Only seven of the 45 different subunits of complex I are encoded by mitochondrial DNA (mtDNA) and mutations in these mitochondrial subunits account for approximately 25% of complex I deficiency (4) . More than half of complex I deficiency is believed to be caused by mutations in ancillary factors necessary for proper complex I assembly and functioning, but to date relatively few patients have been reported to have mitochondrial disease secondary to a mutation in a complex I assembly factor (NDUFAF1 (Dunning, 2007 5 /id) , MIM 606934; NDUFAF2 (7), by guest on hmg.oxfordjournals.org Downloaded from MIM 609653; NDUFAF3 (8) , MIM 612911; NDUFAF4 (9) , MIM 611776; C8ORF38 (10), MIM 612392; and C20ORF7 (11) , MIM 612360). Both mutations in structural complex I subunits and assembly factors reduce the amount of fully assembled functional complex by affecting the rate of complex I assembly and/or its stability (5) . Currently, treatment strategies for isolated complex I deficiency are lacking because of limited insights into its pathophysiology.
We now report a novel disorder affecting complex I activity and stability, caused by a homozygous mutation in the putative molecular chaperone FOXRED1, which we identified by a combined homozygosity mapping and bioinformatics approach.
RESULTS

Biochemistry
Spectrophotometric analysis of respiratory chain enzyme activities revealed severe isolated deficiency of complex I in skeletal muscle from the proband (7% residual activity compared to the mean control, normalized for citrate synthase), with normal activities of other respiratory chain complexes (data not shown). There was a milder deficiency of complex I in patient fibroblasts, with 70% residual activity (data not shown). Immunoblot analysis of onedimensional BN-PAGE gels showed marked reduction of complex I holoenzyme in patient fibroblast mitochondria (Figure 1 ).
Homozygosity Mapping and Bioinformatics Analysis
Previous genetic analysis in this patient had excluded mitochondrial DNA mutations, and mutations in seven structural subunits of complex I (NDUFS2, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFS8 and NDUFV1) as the cause of his complex I deficiency. We then used a homozygosity mapping approach to identify the responsible gene. Whole genome-wide SNP analysis revealed 5 candidate regions of homozygosity in the proband which were not shared with his 5 healthy siblings. These regions were further confirmed by microsatellite analysis, which allowed refinement of these 5 candidate intervals to a total of 50 Mb (Supplementary Table 1 ). These regions contained 338 genes. The longest region of homozygosity (18.3Mb) was observed on chromosome 6, but did not contain any candidate genes implicated in complex I function. The third largest region of homozygosity (9.2 Mb on chromosome 18) contained the only known structural subunit of complex I located within these homozygous intervals: NDUFV2 (MIM 600532; NM_021074).
The remaining 337 genes within the candidate regions were prioritized by bioinformatic analyses including integration with the MitoCarta catalog (10) and 11 genes encoding known or predicted mitochondrial proteins were selected for sequence analysis (Supplementary Table   2 ).
DNA Sequence Analysis
No mutations were identified in NDUFV2. Only one possibly pathogenic mutation was identified in the other eleven genes sequenced: a homozygous c.1054C>T (p.R352W) mutation present in both predicted transcripts of FOXRED1 (NM_017547) on chromosome 11q24.2 ( Figure 2 ). Both parents of the proband were heterozygous for the mutation, as were two of his siblings. Three siblings were homozygous for the wild-type sequence ( Figure 3 ).
The mutation was not found in 268 pan-ethnic healthy control alleles. Sequence analysis of 24 further patients with isolated complex I deficiency without a genetic diagnosis did not reveal any mutations in FOXRED1. The arginine at position 352 of the FOXRED1 protein is highly conserved through evolution (Figure 4) . 
Lentiviral-mediated Complementation and Silencing studies
Mitochondrial complex I activity in patient fibroblasts was shown to be ~70% of controls, relative to residual complex IV activity, using the mitochondrial dipstick assay kits ( Figure   5A ), which was in agreement with the spectrophotometric assays. Expression of a synthetic FOXRED1 gene in patient fibroblasts, using a lentiviral vector, rescued the complex I activity to ~90% of control levels ( Figure 5A ), providing evidence that the R352W missense mutation in FOXRED1 was the cause of the observed complex I deficiency in the patient. However transfection with empty vector also increased complex I activity in patient fibroblasts slightly ( Figure 5A ). The mild deficiency of complex I in patient fibroblasts probably explains why only a 10-20% increase in complex I activity was observed after lentiviral transfection with wild-type FOXRED1 cDNA compared to transfection with empty vector.
Western blot analysis showed a reduced steady state level of FOXRED1 in patient fibroblasts, which increased after lentiviral transduction with wild-type FOXRED1 cDNA ( Figure 5B 
FOXRED1 Protein Modelling
The FOXRED1 (Uniprot AC: Q96CU9; ID: FXRD1_HUMAN) sequence was used to search the PDB using a profile generated vs. the Swiss-Prot database (13) with four iterations of PSI-BLAST (14) . PSI-BLAST was run with a profile inclusion score of 0.001 and default parameters otherwise. Several potential templates were identified; these were consistently related to the sarcosine oxidases. The top hit reported by the PSIBLAST run was 2gb0, a monomeric sarcosine oxidase from Bacillus spp. (15) . The alignment was edited manually to ensure that the secondary structure of the observed template agreed with the prediction made by PSIPRED (16) . The residue of interest, R352 in FOXRED1, aligns to F256 in the template, which is at the end of a short strand in the central sheet of the second domain in 2gb0 
mRNA Coexpression Analysis
Bioinformatics analysis using the mouse GNF1M tissue atlas showed a strong positive correlation between expression of FOXRED1 and expression of known complex I subunits (Supplementary Figure 2) , implying a functional association. This correlation was stronger than for all previously identified assembly factors for complex I.
DISCUSSION
We used an integrative genomics approach, combining homozygosity mapping and bioinformatic analyses, to investigate a consanguineous Iranian-Jewish family in which the sixth child was affected by early-onset complex I deficient encephalomyopathy. Five candidate regions of homozygosity, unique to the proband and not shared with unaffected siblings, were identified by whole genome-wide SNP analysis. No mutations were identified in NDUFV2, the only known structural subunit of complex I located within the homozygous intervals. 337 other genes located within the candidate regions were prioritized by bioinformatic analyses, and 11 genes encoding known or predicted mitochondrial proteins were sequenced.
The only pathogenic mutation identified in these 11 genes was a homozygous missense mutation c.1054C>T in FOXRED1. This mutation segregated with disease in the family; both parents and two siblings were heterozygous for the mutation, whilst the other three siblings were homozygous for the wild type sequence. The mutation was not found in 268 pan-ethnic healthy control alleles. Western blot analysis showed a reduced steady state level of Comparatively little is understood about the assembly process of complex I. The enzyme is Lshaped, containing membrane and matrix arms, and has three functional modules: the dehydrogenase N module (responsible for accepting electrons from NADH), the hydrogenase Q module (transfers electrons to coenzyme Q10) and the proton translocase P module (transfers protons across the inner mitochondrial membrane, IMM). The matrix arm contains the N and Q modules, whilst the P module is located in the membrane arm. Various models have been suggested for complex I assembly, but the current consensus model proposes that the ND1 core subunit anchors an early Q subassembly to the IMM, then further subunits and/or subassemblies are added to both the Q and P modules, and finally the N module is added to form the complex I holoenzyme (5). However, the precise order of subunit incorporation into the nascent enzyme is not known, nor the nature and number of additional factors required for integrity of the assembly process.
Human complex I deficiency has previously been linked to mutations in six complex I assembly factor genes (see above). Studies of assembly intermediates in fibroblasts from patients carrying mutations in these 6 genes have suggested that NDUFAF1 and C20ORF7
are involved early in complex I assembly, whilst NDUFAF2 appears to function at a later stage (7), (23), (11 (10) . It is likely that many more assembly factors of complex I will be identified, bearing in mind that the much smaller complex IV, which has only 13 subunits, requires more than 15 assembly factors for its assembly (24) .
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There does not appear to be any particular genotype phenotype correlation for the complex I assembly disorders, in common with many mitochondrial disorders (Table 1) . Most patients presented with a progressive encephalopathy, frequently fulfilling the criteria for Leigh syndrome (25) . Hypertrophic cardiomyopathy was observed in the patient with NDUFAF1 mutations, as well as our patient with FOXRED1 mutations. All patients had lactic acidaemia, except for those with NDUFAF2 mutations, in whom only CSF lactate levels were elevated.
Severe isolated complex I deficiency was observed in skeletal muscle of all cases (residual activity 0-40% of controls), with normal activities of other respiratory chain enzyme
complexes. There was a suggestion that NDUFAF2 related disease has a characteristic neuroradiological appearance, with a predilection for the mamillothalamic tracts, substantia nigra/medial lemniscus, medial longitudinal fasciculus and spinothalamic tracts, but this has not been found in all cases reported to date.
In the absence of clear genotype-phenotype correlations the approach to a genetic diagnosis for patients with complex I deficiency remains empirical. The first line genetic investigation (after screening for mitochondrial DNA rearrangements and common point mutations m.3243A>G and m.8344A>G) should be complete mitochondrial genome sequence analysis.
Subsequent investigations will be directed at nuclear-encoded structural subunits and known assembly factors of complex I and/or homozygosity mapping in suitable families. However, this approach may not be successful in all cases, since an unknown number of complex I assembly factors remain to be identified, and since complex I deficiency may occasionally be secondary to another disease process, such as 3-hydroxyisobutyryl CoA hydrolase deficiency (26) . Taking into account the costs of sequencing the mitochondrial genome, 38 nuclearencoded structural subunits and at least 7 assembly factors, and the possibility of an underlying defect in a hitherto unrecognized gene, whole exome sequence analysis using next 
MATERIALS AND METHODS
Patient
The patient is the sixth child of healthy Iranian-Jewish first cousin parents. Two sisters and three brothers are unaffected. Pregnancy was uneventful, but soon after birth severe truncal hypotonia was noted. There have never been any voluntary movements. During the first year he was extremely irritable with prolonged periods of inconsolable crying. Muscle biopsy was performed at four months of age because of persistent elevation of lactate in plasma (6.8 mM, All samples were taken after informed patient/parental consent and the study was approved by the local Ethics Committee.
BN-PAGE Analysis
Assembled respiratory chain complexes were detected using Blue-Native polyacrylamide gel electrophoresis (BN-PAGE), performed as previously described (28) . Samples were obtained 
Genetic Studies
Whole genome-wide SNP genotyping was performed in the Iranian-Jewish proband and his unaffected siblings using the GeneChip Human Mapping 10K Xba Array (Affymetrix). We assumed an autosomal recessive model and the output data was analysed assuming more than 30 consecutive homozygous SNPs as being significant. Five regions of significant homozygosity were observed in the patient but not his unaffected siblings and these were further confirmed by microsatellite analysis. Microsatellites were selected using the Ensembl
Human Genome Browser and PCR reactions were carried out using 5' fluorescently labelled forward primers (primer sequences available upon request). After PCR amplification, the labelled DNA fragments were diluted 1/10 to 1/18 and then run together with the ET550-R instructions. Samples were denaturated at 95ºC for 2min and, placed on ice before loading.
Sample injection was at 3000V for 45s. The data were analyzed using Genetic Profiler software v2.2 (Amersham Biosciences). The genes within the candidate regions were prioritized by bioinformatic analyses including integration with the MitoCarta catalogue (10).
DNA Sequence Analysis
Eleven genes were sequenced by cycle sequencing (Big Dye v3.1 Terminator System) and analysis on the MegaBACE™ (Supplementary Table 2 ). Primer sequences for FOXRED1 are given in Supplementary Table 3 
Western Blot Analysis
Western blot analysis was performed as described elsewhere (28) 
Preparation of Lentiviral Vectors
A synthetic codon-optimised FOXRED1 gene was designed to include a Kozak sequence (to increase translational initiation) and two STOP codons (to ensure efficient termination) and was generated by assembly of synthetic oligonucleotides (Genart, Regensburg). The gene was then subcloned into a lentiviral vector (29) and expression linked to eGFP through an internal ribosomal entry sequence (IRES). This vector utilizes a strong retroviral promoter element derived from the spleen focus forming virus (SFFV) and a mutated woodchuck post translational regulatory element (WPRE). Vector stocks were pseudotyped with the vesicular stomatitis virus (vsv) envelope as previously described (30) . Vector stocks of pGIPZ, a 
Complementation Studies
Patient fibroblasts were cultured in DMEM and transduced with lentiviral vector expressing eGFP alone or in combination with FOXRED1. Transduced cells were enriched for eGFP expression by FACS and expanded for functional studies.
RNA Interference Studies
Silencing the FOXRED1 gene in control fibroblasts was achieved by transducing the cells with pGIPZ shRNAmir vector. Stably transduced clones were selected in 1µg/ml puromycin (Gibco-Invitrogen). FOXRED1 silenced fibroblasts died within 20 days of culture following viral transduction.
Sub-mitochondrial Fractionation
Mitochondria from cultured HeLa S3 cells were isolated by differential centrifugation as previously reported (31) . To sub-fractionate mitochondria, the swell-shrink procedure was used as described (32) , except that the inner membrane fraction was further purified by extraction in 10 mM Hepes·NaOH (pH 7.4), 0.5 mM EDTA, 125 mM sucrose, and 0.5% (v/v) TritonX-100 on ice for 30 min, followed by centrifugation at 160,000×g, 4°C for 1 h. To distinguish soluble and peripheral membrane proteins from integral membrane proteins, mitochondria were extracted with the alkaline carbonate method (33) .
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Purity of the sub-fractionated mitochondrial compartments was tested by probing with antibodies to detect a specific marker for each sub-mitochondrial fraction: VDAC (~30kDa;
Calbiochem, 86-173/016, clone 31HL) was used as an OM marker, cytochrome-c (~12kDa; BD Pharmingen, 556433) for the IMS, and MTCO2 (26kDa; Mitosciences, MS405, clone 12C4-F12) for the IM.
Protein Modelling
PSI-BLAST (14) searches against the PDB resulted in several sarcosine oxidase hits. The model was generated using the Bacillus structure 2gb0 (15) . Manual alignment editing was used to improve agreement with the secondary structure prediction generated by PSIPRED (16) . The model was generated using MODELLER (17) with intermediate refinement (library schedule 1, 300 refinement cycles, 3 repeats, max PDF value 1e-06); all non-protein atoms were inherited. Sidechain packing was re-optimized using SCWRL3 (18) . All images were generated using PyMOL (19) . 
FOXRED1 protein evolutionary conservation
The FOXRED1 protein has a well conserved module in its structure across species. Within a part of this module we found that the R352 residue is highly conserved across species, by guest on hmg.oxfordjournals.org
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suggesting that the amino acid change R352W is likely to have a significant functional impact.
Figure 5A
Mitochondrial complex I/IV dipstick assay Dipstick assay shows ~70% residual complex I activity in patient fibroblasts (Fbs) which is recovered to ~90% after complementation with synthetic wild-type FOXRED1 cDNA. A slight recovery is also seen after transfecting patient Fbs with empty vector. FOXRED1-silenced fibroblasts show a ~40% decrease in complex I activity compared to scrambled fibroblasts.
Key: Fbs = fibroblasts; RS = reference sample; FR1 = FOXRED1.
Figure 5B
Western blot analysis
Western blot analysis shows a gain in FOXRED1 and NDUFA9 protein content in patient fibroblasts when complemented with FOXRED1 wild-type cDNA, compared to patient fibroblasts transduced with empty vector. FOXRED1 silenced fibroblasts show a reduction in FOXRED1 and NDUFA9 protein content compared to control and scrambled fibroblasts.
Probing for MTCO2 (anti-complex IV) demonstrated equal loading. Densitometry measurements were carried out using the Alpha Ease FC software (Alpha Innotech/Cell Biosciences, Santa Clara, CA) and confirmed the observations above. 
